Delaware’s Injury & Medical Malpractice Leaders

Helping Victims Of Actemra Complications

Actemra was developed by Genentech and is used in the U.S. for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. It has been on the market in the U.S. since 2010. It has also gained FDA approval for the treatment of Giant Cell Arteritis.

While many arthritis medications on the market have been known to carry risk of heart failure, stroke and lung disease, there was no warning issued for these risks with Actemra.

However, that does not mean there was no risk. In fact, reports have found that hundreds of people taking Actemra have died from these conditions, and untold more have been hurt. At Young Conaway Stargatt & Taylor, LLP, our lawyers can help you determine if you or a loved one has a viable claim for compensation if Actemra has caused you harm.

If you are taking Actemra to treat your arthritis, you need to be on the lookout for the following potentially life-threatening complications and side effects:

  • Stroke
  • Heart attack and heart failure
  • Lung disease
  • Pancreatitis
  • Gastrointestinal perforation

Seek Help Today By Scheduling A Free Consultation

If you or a loved one is suffering from the effects of Actemra, we invite you to contact our law firm, Young Conaway Stargatt & Taylor, LLP, today. Our team of experienced personal injury attorneys has a lengthy track record of holding drug manufacturers accountable for causing wrongful death and serious injuries.

We have an office in Wilmington, to better serve clients throughout Delaware. You can schedule your free consultation online or by calling 302-298-0370.